In a strategic move underscoring its commitment to international collaboration and healthcare innovation, King Faisal Specialist Hospital & Research Centre (KFSHRC) welcomed Dr. Patrick Soon-Shiong, Executive Chairman of ImmunityBio, during an official visit that addressed opportunities for collaboration in precision medicine and scientific research. The visit included a tour of KFSHRC’s Centers of Excellence, highlighting the role of scientific cooperation in accelerating medical breakthroughs and advancing biotechnological innovation.
Dr. Majid AlFayyadh, CEO of KFSHRC, emphasized that this engagement marks a strategic step in strengthening institutional partnerships with global leaders in medicine and research. “This meeting is part of our broader mission to enhance the patient experience, accelerate the adoption of advanced medical solutions, and reinforce KFSHRC’s position as a global reference in healthcare and research excellence,” he stated.
These efforts align with the goals of Saudi Vision 2030, reaffirming KFSHRC’s role in elevating healthcare quality through collaboration with pioneering institutions and international scientific leadership.
It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world’s top 250 Academic Medical Centres for 2025 and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, it was included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine.
For more information, visit www.kfshrc.edu.sa or contact our media team at mediacoverage@kfshrc.edu.sa